Safety assessment of a newly synthesized copolymer for micellar delivery of hydrophobic caffeic acid phenethyl ester

References

• Ahmad A, Khan JM, Haque S. 2019. Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles. Biochimie. 160:61–75.
   PubMed Web of Science ®Google Scholar
• Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR, Akyol O. 2013. In vivo and in vitro antineoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives. Nutr Cancer. 65(4):515–526.
   PubMed Web of Science ®Google Scholar
• Akyol S, Ugurcu V, Altuntas A, Hasgul R, Cakmak O, Akyol O. 2014. Caffeic acid phenethyl ester as a protective agent against nephrotoxicity and/or oxidative kidney damage: a detailed systematic review. Sci World J. 2014:1–16.
   Google Scholar
• Aluani D, Tzankova V, Kondeva-Burdina M, Yordanov Y, Nikolova E, Odzhakov F, Apostolov A, Markova T, Yoncheva K. 2017. Еvaluation of biocompatibility and antioxidant efficiency of chitosan–alginate nanoparticles loaded with quercetin. Int J Biol Macromol. 103:771–782.
   PubMed Web of Science ®Google Scholar
• Anjaly K, Tiku AB. 2018. Radio-modulatory potential of caffeic acid phenethyl ester: a therapeutic perspective. Anticancer Agents Med Chem. 18(4):468–475.
   PubMed Web of Science ®Google Scholar
• Armutcu F, Akyol S, Ustunsoy S, Turan FF. 2015. Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects. Exp Ther Med. 9(5):1582–1588.
   PubMed Web of Science ®Google Scholar
• Bai X, Qiu A, Guan J, Shi Z. 2007. Antioxidant and protective effect of an oleanolic acid-enriched extract of A. deliciosa root on carbon tetrachloride induced rat liver injury. Asia Pac J Clin Nutr. 16(Suppl. 1):169–173.
   PubMedGoogle Scholar
• Bankova V, Trusheva B, Popova M. 2018. Caffeic acid phenethyl ester (CAPE) – natural sources, analytical procedures and synthetic approaches. “Prof. Marin Drinov” Publishing House of Bulgarian Academy of Sciences; [accessed 2019 Jun 26]. http://www.proceedings.bas.bg/DOI/doi2018_9_01.html.
   Google Scholar
• Bernas T, Dobrucki J. 2002. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry. 47(4):236–242.
   PubMedGoogle Scholar
• Berridge MV, Herst PM, Tan AS. 2005. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. In: Biotechnology annual review. Vol. 11. Elsevier; p. 127–152; [accessed 2014 Nov 3]. http://linkinghub.elsevier.com/retrieve/pii/S1387265605110047.
   Google Scholar
• Boya P, Kroemer G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene. 27(50):6434–6451.
   PubMed Web of Science ®Google Scholar
• Celli N, Dragani LK, Murzilli S, Pagliani T, Poggi A. 2007. In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis. J Agric Food Chem. 55(9):3398–3407.
   PubMed Web of Science ®Google Scholar
• Chan FK-M, Moriwaki K, De Rosa MJ. 2013. Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol Biol. 979:65–70.
   PubMedGoogle Scholar
• Di L, Kerns EH. 2015. Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization. London: Academic Press.
   Google Scholar
• Erdemli HK, Akyol S, Armutcu F, Akyol O. 2015. Antiviral properties of caffeic acid phenethyl ester and its potential application. J Intercult Ethnopharmacol. 4(4):344–347.
   PubMedGoogle Scholar
• Erdemli HK, Akyol S, Armutcu F, Gulec MA, Canbal M, Akyol O. 2016. Melatonin and caffeic acid phenethyl ester in the regulation of mitochondrial function and apoptosis: the basis for future medical approaches. Life Sci. 148:305–312.
   PubMed Web of Science ®Google Scholar
• Erra Díaz F, Dantas E, Geffner J. 2018. Unravelling the interplay between extracellular acidosis and immune cells. Mediators Inflamm. 2018:1218297.
   PubMed Web of Science ®Google Scholar
• Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, Nelson HM, Giorgio TD, Duvall CL. 2013. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp. 73:e50166.
   Google Scholar
• Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK. 2004. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol. 24(1):47–52.
   PubMed Web of Science ®Google Scholar
• Fotakis G, Timbrell JA. 2006. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett. 160(2):171–177.
   PubMed Web of Science ®Google Scholar
• Gurel A, Armutcu F, Sahin S, Sogut S, Ozyurt H, Gulec M, Kutlu NO, Akyol O. 2004. Protective role of alpha-tocopherol and caffeic acid phenethyl ester on ischemia-reperfusion injury via nitric oxide and myeloperoxidase in rat kidneys. Clin Chim Acta. 339(1–2):33–41.
   PubMed Web of Science ®Google Scholar
• Hanafy NAN, El-Kemary M, Leporatti S. 2018. Micelles structure development as a strategy to improve smart cancer therapy. Cancers. 10(7):238.
   Web of Science ®Google Scholar
• Ketkar S, Pagire SK, Goud NR, Mahadik K, Nangia A, Paradkar A. 2016. Tracing the architecture of caffeic acid phenethyl ester cocrystals: studies on crystal structure, solubility, and bioavailability implications. Cryst Growth Des. 16(10):5710–5716.
   Web of Science ®Google Scholar
• Korzeniewski C, Callewaert DM. 1983. An enzyme-release assay for natural cytotoxicity. J Immunol Methods. 64(3):313–320.
   PubMed Web of Science ®Google Scholar
• Kuo Y-Y, Jim W-T, Su L-C, Chung C-J, Lin C-Y, Huo C, Tseng J-C, Huang S-H, Lai C-J, Chen B-C, et al. 2015. Caffeic acid phenethyl ester is a potential therapeutic agent for oral cancer. Int J Mol Sci. 16(5):10748–10766.
   PubMed Web of Science ®Google Scholar
• Lin H-P, Lin C-Y, Liu C-C, Su L-C, Huo C, Kuo Y-Y, Tseng J-C, Hsu J-M, Chen C-K, Chuu C-P. 2013. Caffeic acid phenethyl ester as a potential treatment for advanced prostate cancer targeting Akt signaling. Int J Mol Sci. 14(3):5264–5283.
   PubMed Web of Science ®Google Scholar
• Magnani C, Isaac VLB, Correa MA, Salgado HRN. 2014. Caffeic acid: a review of its potential use in medications and cosmetics. Anal Methods. 6(10):3203–3210.
   Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65(1–2):55–63.
   PubMed Web of Science ®Google Scholar
• Murtaza G, Sajjad A, Mehmood Z, Shah SH, Siddiqi AR. 2015. Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer. J Food Drug Anal. 23(1):11–18.
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Banskota AH, Tezuka Y, Saiki I, Kadota S. 2002. Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26-L5 carcinoma cell line. Bioorg Med Chem. 10(10):3351–3359.
   PubMed Web of Science ®Google Scholar
• Ojer P, Iglesias T, Azqueta A, Irache JM, López de Cerain A. 2015. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs. Eur J Pharm Biopharm. 97(Pt A):206–217.
   PubMedGoogle Scholar
• Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A, Akyol O. 2012. The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci. 16(15):2064–2068.
   PubMed Web of Science ®Google Scholar
• Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, Acet A. 2005. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology. 207(2):169–177.
   PubMed Web of Science ®Google Scholar
• Pittalà V, Salerno L, Romeo G, Acquaviva R, Di Giacomo C, Sorrenti V. 2018. Therapeutic potential of caffeic acid phenethyl ester (CAPE) in diabetes. Curr Med Chem. 25(37):4827–4836.
   PubMed Web of Science ®Google Scholar
• Ross MK, Borazjani A, Wang R, Crow JA, Xie S. 2012. Examination of the carboxylesterase phenotype in human liver. Arch Biochem Biophys. 522(1):44–56.
   PubMed Web of Science ®Google Scholar
• Sassa S, Sugita O, Galbraith RA, Kappas A. 1987. Drug metabolism by the human hepatoma cell, Hep G2. Biochem Biophys Res Commun. 143(1):52–57.
   PubMed Web of Science ®Google Scholar
• Savjani KT, Gajjar AK, Savjani JK. 2012. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012:195727.
   PubMedGoogle Scholar
• Seyfert UT, Biehl V, Schenk J. 2002. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng. 19(2–6):91–96.
   PubMedGoogle Scholar
• Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, et al. 2013. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 8(10):772–781.
   PubMed Web of Science ®Google Scholar
• Theerakittayakorn K, Bunprasert T. 2011. Differentiation capacity of mouse L929 fibroblastic cell line compare with human dermal fibroblast. World Acad Sci Eng Technol Int J Med Health Sci. 5(2):4.
   Google Scholar
• Tolba MF, Azab SS, Khalifa AE, Abdel-Rahman SZ, Abdel-Naim AB. 2013. Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects. IUBMB Life. 65(8):699–709.
   PubMed Web of Science ®Google Scholar
• Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. 2016. Caffeic acid phenethyl ester: a review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions. Crit Rev Food Sci Nutr. 56(13):2183–2190.
   PubMed Web of Science ®Google Scholar
• Valchanova M, Yordanov Y, Tzankova V, Yoncheva K, Turmanova S, Rangelov S. 2019. Functional amphiphilic block copolyethers as carriers of caffeic acid phenethyl ester. Polym Int. 68(11):1881–1890.
   Web of Science ®Google Scholar
• Walkey CD, Chan WCW. 2012. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 41(7):2780–2799.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Sforcin J. 2018. Effects of propolis and caffeic acid phenethyl ester (CAPE) on breast cancer cells. Curr Pharmacogenom Personal Med. 16(2):88–93.
   Google Scholar
• Weber M, Steinle H, Golombek S, Hann L, Schlensak C, Wendel HP, Avci-Adali M. 2018. Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility. Front Bioeng Biotechnol. 6:99.
   PubMed Web of Science ®Google Scholar
• Wu W, Lu L, Long Y, Wang T, Liu L, Chen Q, Wang R. 2007. Free radical scavenging and antioxidative activities of caffeic acid phenethyl ester (CAPE) and its related compounds in solution and membranes: a structure–activity insight. Food Chem. 105(1):107–115.
   Web of Science ®Google Scholar
• Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. 2004. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta. 348(1–2):27–34.
   PubMed Web of Science ®Google Scholar
• Yordanov Y. 2019a. Caffeic acid phenethyl ester (CAPE): pharmacodynamics and potential for therapeutic application. Pharmacia. 66(3):107–114.
   Web of Science ®Google Scholar
• Yordanov Y. 2019b. Caffeic acid phenethyl ester (CAPE): cornerstone pharmacological studies and drug delivery systems. Pharmacia. 66(4):223–231.
   Web of Science ®Google Scholar
• Zhao B, Wang X-Q, Wang X-Y, Zhang H, Dai W-B, Wang J, Zhong Z-L, Wu H-N, Zhang Q. 2013. Nanotoxicity comparison of four amphiphilic polymeric micelles with similar hydrophilic or hydrophobic structure. Part Fibre Toxicol. 10(1):47.
   PubMedGoogle Scholar